Scienmag

NOVEMBER 18, 2020

Jude Children’s Research Hospital scientists […]. Jude Children’s Research Hospital The COVID-19 pandemic continues to cause significant illness and death while treatment options remain limited.

Scientist 98

Scientist Research Drugs Allergies 98

Scienmag

JULY 19, 2021

The Mark Foundation for Cancer Research funds Jackson Laboratory scientists to take on immunotherapy’s greatest challenges — improving response rates and decreasing debilitating side effects The Mark Foundation for Cancer Research announces a $1 million grant to The Jackson Laboratory (JAX) to study the harmful side effects that sometimes (..)

Scientist 75

Scientist Research Allergies Genetics 75

Drug Discovery World

JUNE 30, 2023

Whether it be a monoclonal antibody to treat peanut allergy, or using artificial intelligence (AI) to identify influenza drug targets, each discovery reflects the level of scientific innovation and diversity of approaches being employed in drug development today. The top stories: Could a monoclonal antibody treat peanut allergy?

Allergies 52

Allergies Drugs Antibody Regulation 52

Scienmag

MARCH 5, 2021

Scientists at Walter Reed Army Institute of Research, in a collaboration the Duke University, have confirmed that monoclonal antibodies can be an effective tool in the global fight against malaria.

Scientist 74

Scientist Antibody Research Allergies 74

Scienmag

NOVEMBER 1, 2021

By studying a disease caused by a close cousin of the virus behind COVID-19, a team of scientists has identified a compound that shows potential in easing the symptoms of coronavirus infections. Credit: Photo courtesy of National Institute of Allergy and Infectious Diseases, NIH RICHLAND, Wash.—By RICHLAND, Wash.—By

Allergies 77

Allergies Scientist Medicine 77

Scienmag

APRIL 16, 2021

– April 16, 2021 – Scientists at Sanford Burnham Prebys have identified a set of human genes that fight SARS-CoV-2 infection, the virus that causes COVID-19. Credit: Dotted Yeti LA JOLLA, CALIF.

Gene 60

Gene Scientist Research Allergies 60

Scienmag

JUNE 1, 2021

Army scientists working as part of an international consortium have developed and tested an antibody-based therapy to treat Crimean-Congo hemorrhagic fever virus (CCHFV), which is carried by ticks and kills up to 60 percent of those infected. Their results are published online today in the journal Cell.

Scientist 57

Scientist Development Antibody Allergies 57

Delveinsight

AUGUST 6, 2020

Scientists have already isolated many highly potent neutralizing antibodies from patients who recovered from COVID-19. FDA turns back peanut allergy patch of DBV Technologies. A peanut allergy patch which is based on new delivery technology has hit a snag at the FDA. The agency raised no safety concerns.

Allergies 53

Allergies Vaccination Vaccine Gene Therapy 53

Scienmag

OCTOBER 6, 2020

Scientists in the US and UK publish first in-depth look at how CD4+ T cells fight SARS-CoV-2 Credit: NIAID LA JOLLA–As scientists around the world develop life-saving COVID-19 vaccines and therapies, many are still wondering exactly why the disease proves deadly in some people and mild in others.

Scientist 40

Scientist Vaccination Vaccine Development 40

Scienmag

MARCH 4, 2021

COVID genetic mystery, power outage costs, Alzheimer pathology, optical antennas Credit: National Institute of Allergy and Infectious Diseases-Rocky Mountain Laboratories, NIH Solving a Genetic Mystery at the Heart of the COVID-19 Pandemic As the COVID-19 pandemic enters its second year, scientists are still working to understand how the new strain (..)

Allergies 55

Allergies Genetics Scientist Medicine 55

Scienmag

JANUARY 11, 2021

Scientists reach new milestone in vaccine development for neglected tropical disease Researchers have taken an important step forward in developing a controlled human infection model to test leishmaniasis vaccines.

Scientist 40

Scientist Vaccination Vaccine Development 40

Drug Discovery World

JANUARY 12, 2024

The top stories: Excitement over new antibiotics that can kill drug-resistant bacteria A novel antibiotic class targeting a major global pathogen and threat to human health has been discovered by scientists from Roche and Harvard University (Cambridge, MA, US).

Drugs 52

Drugs Immune Response Allergies Bacteria 52

Scienmag

MAY 3, 2021

Researchers who elucidated key functions of RNA, the workhorse molecule of cells, will be honored in October The 2021 Warren Alpert Foundation Prize has been awarded to scientists Lynne Maquat and Joan Steitz for seminal discoveries in the biology and function of RNA, the workhorse molecule of cells.

RNA 41

RNA Scientist Research Allergies 41

Scienmag

SEPTEMBER 4, 2020

Anticholinergic medications are used for many conditions but might also accelerate cognitive decline, especially in older persons with biological or genetic risk factors A team of scientists, led by researchers at University of California San Diego School of Medicine, report that a class of drugs used for a broad array of conditions, from allergies (..)

Allergies 41

Allergies Drugs Genetics Scientist 41

Drug Discovery World

DECEMBER 18, 2023

An effective HIV vaccine may need to prompt strong responses from CD8+ T cells to protect people from acquiring HIV, according to a study from the National Institute of Allergy and Infectious Diseases (NIAID).

Vaccination 57

Vaccination Vaccine Allergies Clinical Trials 57

pharmaphorum

NOVEMBER 11, 2022

Marc Pelletier , Senior Principal Scientist – Translational Immune Oncology, Novartis. Giulia D’Urso , Senior Clinical Scientist, Hoffmann- La Roche. Alan Watt , Chief Scientific Officer, NodThera. Stephen Glover , Co-Founder, Chairman & Chief Executive Officer, ZyVersa.

Allergies 52

Allergies Scientist Medicine Development 52

Drug Discovery World

JANUARY 31, 2024

As such, the SLAS award opportunities, such as the SLAS Tony B Travel Award Program and the Student Poster Award, show the organisation’s commitment to providing a platform from the very beginning of a researcher or scientist’s career, as well as the importance of keeping new ideas pride of place.

Gene Therapy 52

Gene Therapy Allergies Scientist Gene 52

pharmaphorum

JANUARY 18, 2021

That was equivalent to 11 cases per million doses, according to the agency, which says the reactions can be managed using patient screening for allergies, observation periods after dosing and having epinephrine injections on hand as a precaution.

Vaccination 136

Vaccination Vaccine Allergies Scientist 136

Scienmag

FEBRUARY 25, 2021

Research from the California Institute of Technology shows exactly how antibodies stick to and block the Zika virus, which will inform vaccine development Credit: Image courtesy of Shannon Esswein.

Antibody 52

Antibody Scientist Vaccination Vaccine 52

Scienmag

AUGUST 14, 2020

Finding could lead to genetic tests that identify infants at risk for the disease Credit: NIAID WHAT: New research supported by the National Institutes of Health delineates how two relatively common variations in a gene called KIF3A are responsible for an impaired skin barrier that allows increased water loss from the skin, promoting the development (..)

Genetics 52

Genetics Scientist Gene Development 52

Drug Discovery World

AUGUST 5, 2022

An international team of researchers has won £30 million for its work in developing a potential cure for inherited heart muscle conditions in young people. New insights into HIV latent cells yield potential cure targets.

Drugs 52

Drugs Allergies Scientist Research 52

Scienmag

APRIL 22, 2021

SARS-CoV-2 can recruit a haem metabolite to evade antibody immunity Researchers have identified another potential target for neutralizing antibodies on the SARS-CoV-2 Spike protein that is masked by metabolites in the blood.

Antibody 46

Antibody Protein Scientist Research 46

pharmaphorum

AUGUST 7, 2020

After the initial first success as a monotherapy, scientists are now trialling it in combination with other drugs to see if the antiviral effect is enhanced. Earlier this week the US-government backed National Institutes of Health begun a trial testing remdesivir in combination with interferon beta-1a – Merck KGaA’s Rebif – against COVID-19.

Manufacturing 119

Manufacturing Contract Manufacturing Protein Allergies 119

Scienmag

JULY 14, 2021

Scientists report that the alternative-splicing regulator NSrp70 influences immune T cell development Credit: Gwangju Institute of Science & Technology T lymphocytes, or T cells, are immune cells with diverse roles in building the body’s immunity. How does one particular cell type fight against a host of different pathogens?

Regulation 98

Regulation Scientist Development Allergies 98

XTalks

SEPTEMBER 8, 2020

The funding for the trial is being supported by the National Institute of Allergy and Infectious Diseases (NIAID) and the Biomedical Advanced Research and Development Authority (BARDA). AstraZeneca, a UK-based global pharmaceutical company, is leading the COVID-19 trial as a regulatory sponsor. Fauci, in a statement.

Manufacturing 83

Manufacturing Vaccination Vaccine Allergies 83

Scienmag

MAY 26, 2021

Credit: HKUST In a new study, scientists at The Hong Kong University of Science and Technology (HKUST) have revealed that most T cell epitopes known to be targeted upon natural infection are seemingly unaffected by current SARS-CoV-2 variants.

Scientist 96

Scientist Research Allergies Vaccination 96

Scienmag

JULY 21, 2021

Harnessing the combined power of Vitamin C and TET proteins may give scientists a leg up in treating autoimmune diseases Credit: La Jolla Institute for Immunology LA JOLLA, CA–You can’t make a banana split without bananas.

Protein 95

Protein Scientist Allergies 95

Scienmag

SEPTEMBER 14, 2020

Thanks to the sniffling noses, coughs, and colds that accompany the colder months of the year, we are all too familiar with the seasonal patterns of some respiratory viruses.

Scientist 42

Scientist Allergies Vaccination Vaccine 42

Scienmag

JANUARY 21, 2021

The year 2021 marks the 100th anniversary of a fundamental discovery that’s taught in every biochemistry textbook.

Scientist 45

Scientist Allergies Medicine 45

Drug Discovery World

JULY 8, 2022

Speakers at this year’s event include Anthony Fauci, Director of the National Institute of Allergy and Infectious Diseases at the NIH, and Muhammad Ali Pate, Global Director of Health, Population and Nutrition at the World Bank. . Official comments ? .

Vaccination 52

Vaccination Vaccine Allergies Bacteria 52

Scienmag

MARCH 29, 2021

– New research led by scientists at Washington State University has found that a protein known as GBP5 appears to play a key role in suppressing inflammation in rheumatoid arthritis, a potentially debilitating disease in which the immune system mistakenly attacks the […].

Protein 88

Protein Scientist Research Allergies 88

Drug Discovery World

DECEMBER 6, 2022

While scientists have struggled in the past to create an effective vaccine against HIV, a novel vaccine design strategy shows new promise, according to data from a first-in-human clinical trial. . Steps to producing bnAbs. Immune cells were isolated from recipients who received the vaccine or placebo.

Vaccination 52

Vaccination Vaccine Trials Antibody 52

Scienmag

AUGUST 9, 2020

Credit: Phil Jones, Senior Photographer, Augusta University When the eye isn’t getting enough oxygen in the face of common conditions like premature birth or diabetes, it sets in motion a state of frenzied energy production that can ultimately result in blindness, and now scientists have identified new points where they may be able to calm […]. (..)

Scientist 96

Scientist Production Allergies Medicine 96

Scienmag

MARCH 17, 2021

Credit: Georgia State University ATLANTA–Dr.

Scientist 59

Scientist Development Allergies Medicine 59

Scienmag

JANUARY 24, 2021

(January 25, 2021) – Immediately after a traumatic brain injury and as long as one year later, there are increased levels of immune cells called ILCs in the brain promoting inflammation, which can worsen brain damage, scientists report. They also report for the first time that the […].

Scientist 86

Scientist Allergies Medicine 86

Scienmag

DECEMBER 4, 2020

LJI scientists get first glimpse of how mysterious particles break off of immune cells Credit: Alex Marki, Ph.D., The scientists are the first to show that these […].

Research 55

Research Scientist Allergies Medicine 55

XTalks

APRIL 24, 2024

April marks not only the blossoming of spring and the onslaught of my allergies but also a pivotal moment for raising awareness and advocating for equitable healthcare access. There is an urgent need to engage scientists with communities to ensure structured involvement in research on minority health and health disparities.

Research 105

Research Allergies Clinical Trials Clinical Trials 105